A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.

Saved in:
Bibliographic Details
Title: A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.
Authors: Krause DS; Vicuron Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA. dkrause@vicuron.com, Simjee AE, van Rensburg C, Viljoen J, Walsh TJ, Goldstein BP, Wible M, Henkel T
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2004 Sep 15; Vol. 39 (6), pp. 770-5. Date of Electronic Publication: 2004 Aug 27.
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-6591
DOI:10.1086/423378